Update on the diagnosis and treatment of choroidal hemangioma

Arch Soc Esp Oftalmol (Engl Ed). 2023 May;98(5):281-291. doi: 10.1016/j.oftale.2023.04.006. Epub 2023 Apr 14.


Choroidal hemangioma (CH) is a benign vascular tumor dependent on the choroid. Two types of lesions are distinguished: circumscribed (CCH), the most frequent variant, and diffuse (DCH), normally associated with Sturge-Weber syndrome. HCC appears as an orange mass that can present asymptomatically, however, when it produces symptoms, the most frequent is decreased visual acuity due to neurosensory retinal detachment. Due to its benign nature, only those that produce symptoms should be eligible for treatment. Knowledge of this pathology and its correct differential diagnosis is very relevant to establish the appropriate diagnosis and treatment, avoiding unnecessary treatments. There is currently a wide variety of multimodal diagnostic imaging tests that allow us to identify and adequately monitor this tumor. In addition, in recent years, there has been a change in the paradigm of the treatment of these tumors thanks to the use of photodinamic therapy, which has led to a significant improvement in the visual prognosis of these patients. This has been due to the use of photodynamic therapy as the treatment of choice for HCC.

Keywords: Choroidal hemangioma; Choroidal vascular tumor; Desprendimiento neurosensorial; Hemangioma coroideo; Neurosensorial detachment; Photodynamic therapy; Terapia fotodinámica; Tumor vascular coroideo benigno.

Publication types

  • Review

MeSH terms

  • Choroid Neoplasms* / diagnosis
  • Choroid Neoplasms* / therapy
  • Fluorescein Angiography
  • Hemangioma* / diagnosis
  • Hemangioma* / pathology
  • Hemangioma* / therapy
  • Humans
  • Sturge-Weber Syndrome* / complications
  • Sturge-Weber Syndrome* / diagnosis
  • Sturge-Weber Syndrome* / therapy